Deepak Jain, PhD

Chief Operating Officer at ProKidney

Deepak Jain, PhD has over 40 years of experience in the development of tissue engineered and cell therapy products. Dr. Jain is currently the Chief Operating Officer at ProKidney. Previously, Dr. Jain was the COO at Twin City Bio before co-founding and running RegenMed Therapeutics as COO. Earlier, Dr. Jain was Senior Vice President of Bioprocess R&D and Technical Operations at Tengion responsible for bioprocess research, process development and clinical manufacturing of advanced regenerative medicine and cell therapy products including urinary bladder replacement and kidney regeneration. Prior to Tengion, Dr. Jain was the Executive Director of Process Development and Manufacturing Technical Support at Advanced Tissue Sciences responsible for development of two tissue engineered marketed products for therapeutic applications in the skin, cartilage and cardiovascular areas. Dr. Jain has held several positions at Merck and Johnson & Johnson, leading the development of biotechnology products with a focus on recombinant proteins. Dr. Jain was instrumental in the development and manufacturing support of J&J’s multi-billion dollar product for the treatment of anemia. More recently, Dr. Jain was as a full-time consultant for Baxter Corporation responsible for establishing a commercial manufacturing facility overseas for a marketed recombinant protein. Dr. Jain served as the Chairman of Cell Therapy Ad hoc Advisory Panel for United States Pharmacopoeia and served as a member of USP’s Biologics & Biotechnology Expert Committee and as Chairman of the American Society for Testing and Materials Task Group on Preservation of Cells and Tissue Engineered Medical Product’s with Cells.